With $2.4M Grant, Researchers to Collaborate in Study of Heart Disease

After receiving a five-year, $2.4 million grant from the National Institute of Environmental Health Sciences (NIEHS), two University of Cincinnati researchers will collaborate on an investigation of gene-environment interactions during embryonic development and their consequences in adult heart disease.

Alvaro Puga, PhD, of the Department of Environmental Health, and Jack Rubinstein, MD, of the Department of Internal Medicine, Division of Cardiovascular Health and Disease, received the grant from the NIEHS, an institute of the National Institutes of Health (NIH). They will serve as co-principal investigators.

The grant will enable them to study connections between the body’s Ah receptor (AHR) gene, fetal exposure to dioxin and cardiovascular disease. Using mice, they will test the hypothesis that exposure to dioxin during pregnancy redirects AHR functions toward toxic and/or adaptive responses that can lead to adult cardiovascular disease.

"The basic idea of our research is that there is a developmental origin of heart disease,” says Puga, who has studied environmental toxins extensively as a faculty member in the environmental health department’s Division of Environmental Genetics and Molecular Toxicology. He is also an associate director of UC’s Center for Environmental Genetics, which is funded by NIEHS and housed in the environmental health department under the direction of Shuk-mei Ho, PhD, Jacob G. Schmidlapp Professor and Chair of Environmental Health.

Dioxins are highly toxic compounds that are byproducts of industrial processes and are present in the environment. They are ingested into the body orally, Puga says (through eating the meat of cows that have grazed on dioxin-contaminated fields, for example), and stored in fat. Dioxin can be mobilized during pregnancy when fat stores are needed, he says.

Rubinstein says researchers will use a sophisticated high-frequency ultrasound imaging machine to study mice that have been exposed to dioxin, beginning in the womb.

"We can actually measure the heart function and see the structure of the heart before the litters are born,” he says. "So we’ll be able to follow the litters from before birth all the way out after birth and into adulthood.”

Adds Puga: "Congenital cardiovascular malformations are the leading cause of neonatal and infant death and a major cause of adult cardiac insufficiency, and there’s a critical need to understand the mechanisms that causes these diseases.

"This study will establish the role of AHR in cardiac development and help identify gene-environment interactions that may aggravate heart disease susceptibility.”

The collaboration between Rubinstein and Puga was initiated by Vinicius Carreira, a graduate student in the Puga lab and a doctor of veterinary medicine and animal pathologist, who was interested in this project for his doctoral thesis and contacted Rubinstein with the idea.

"His involvement in the project illustrates how critically important the role our graduate students play is in the research done in the College of Medicine,” Puga says.

Related Stories

1

UC students organize free health clinic happening July 11-12

July 10, 2026

The University of Cincinnati student chapter of Remote Area Medical is holding its annual free health clinic July 11-12. The clinic is open to adults and children, with no income requirements. Anyone in the area who needs medical, dental or vision care will have a chance to get it for free, with no insurance required.

2

Is speech-to-text AI really reliable?

July 10, 2026

UC researcher Nelly Elsayed’s study in the International Journal of Medical Informatics reveals key risks in clinical speech-to-text AI and shows why human review is essential.

3

Hoxworth Blood Center CEO advocates on Capitol Hill during National Blood Advocacy Week

July 9, 2026

Hoxworth Blood Center, University of Cincinnati, has announced that David Oh, MD, director and chief executive officer, joined blood center leaders, patient advocates and partner organizations in Washington, D.C., in June as part of Blood Advocacy Week, a national initiative led by America’s Blood Centers to strengthen the nation’s blood supply.